Figure 4
Figure 4. Deficiency of XBP1 or IRE1α compromises MEF and murine BMSC support of MM cell growth. (A) Western blot demonstrating the effect of XBP1 deficiency on baseline and TNFα (10 ng/mL for 24 hours)–induced VCAM-1 protein expression in MEF cells. The basal level VCAM-1 protein expression in XBP1+/+ MEF cells was normalized to β-actin and defined as 1. (B) ELISA assay shows that IL-6 secretion was decreased significantly in XBP1−/− MEF cells compared with XBP1+/+ MEF cells (n = 3; mean ± SD; *P < .05). (C) Effect of XBP1 deficiency on the capacity of MEF cells to support MM cell growth (n = 3, mean ± SD, *P < .05). (D) The effects of TNFα (10 ng/mL for 24 hours) on baseline and TNFα-induced VCAM-1 protein expression in IRE1α+/+ and IRE1α−/− MEF cells, determined by Western blotting. The basal level VCAM-1 protein expression in IRE1α+/+ MEF cells was normalized to β-actin and defined as 1. (E) ELISA assay shows that IL-6 secretion was significantly decreased in IRE1α−/− MEF cells compared with that in IRE1α+/+ MEF cells (n = 3; mean ± SD; *P < .05). (F) Effect of IRE1α deficiency on the capacity of MEF cells to support 5TGM1 cell growth (n = 3, mean ± SD, *P < .05). (G) Effects of murine XBP1 knock-down on the baseline and TNFα (10 ng/mL for 24 hours)–induced VCAM-1 protein expression in mBMSCs. The basal level VCAM-1 protein expression in mBMSCs with control shRNA was normalized to β-actin and defined as 1. (H) Effects of murine XBP1 knockdown on IL-6 secretion in mBMSCs (n = 3; mean ± SD; *P < .05). (I) XBP1 knockdown reduced mBMSC support of 5TGM1 cell growth (n = 3, mean ± SD, *P < .05).

Deficiency of XBP1 or IRE1α compromises MEF and murine BMSC support of MM cell growth. (A) Western blot demonstrating the effect of XBP1 deficiency on baseline and TNFα (10 ng/mL for 24 hours)–induced VCAM-1 protein expression in MEF cells. The basal level VCAM-1 protein expression in XBP1+/+ MEF cells was normalized to β-actin and defined as 1. (B) ELISA assay shows that IL-6 secretion was decreased significantly in XBP1−/− MEF cells compared with XBP1+/+ MEF cells (n = 3; mean ± SD; *P < .05). (C) Effect of XBP1 deficiency on the capacity of MEF cells to support MM cell growth (n = 3, mean ± SD, *P < .05). (D) The effects of TNFα (10 ng/mL for 24 hours) on baseline and TNFα-induced VCAM-1 protein expression in IRE1α+/+ and IRE1α−/− MEF cells, determined by Western blotting. The basal level VCAM-1 protein expression in IRE1α+/+ MEF cells was normalized to β-actin and defined as 1. (E) ELISA assay shows that IL-6 secretion was significantly decreased in IRE1α−/− MEF cells compared with that in IRE1α+/+ MEF cells (n = 3; mean ± SD; *P < .05). (F) Effect of IRE1α deficiency on the capacity of MEF cells to support 5TGM1 cell growth (n = 3, mean ± SD, *P < .05). (G) Effects of murine XBP1 knock-down on the baseline and TNFα (10 ng/mL for 24 hours)–induced VCAM-1 protein expression in mBMSCs. The basal level VCAM-1 protein expression in mBMSCs with control shRNA was normalized to β-actin and defined as 1. (H) Effects of murine XBP1 knockdown on IL-6 secretion in mBMSCs (n = 3; mean ± SD; *P < .05). (I) XBP1 knockdown reduced mBMSC support of 5TGM1 cell growth (n = 3, mean ± SD, *P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal